These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32406248)

  • 1. Diagnostic delay among ALS patients: Egyptian study.
    Rashed HR; Tork MA
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):416-419. PubMed ID: 32406248
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.
    Williams JR; Fitzhenry D; Grant L; Martyn D; Kerr DA
    BMC Neurol; 2013 Nov; 13():160. PubMed ID: 24499173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis.
    He Z; Sun B; Feng F; Bai J; Wang H; Wang H; Yang F; Cui F; Huang X
    Neurol Sci; 2022 Mar; 43(3):1817-1822. PubMed ID: 34383162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort.
    Kacem I; Sghaier I; Bougatef S; Nasri A; Gargouri A; Ajroud-Driss S; Gouider R
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):131-139. PubMed ID: 31858811
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.
    Cellura E; Spataro R; Taiello AC; La Bella V
    Clin Neurol Neurosurg; 2012 Jul; 114(6):550-4. PubMed ID: 22169158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis.
    Richards D; Morren JA; Pioro EP
    J Neurol Sci; 2020 Oct; 417():117054. PubMed ID: 32763509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting survival in ALS: a multicenter Italian study.
    Calvo A; Moglia C; Lunetta C; Marinou K; Ticozzi N; Ferrante GD; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Chiò A; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Riva N; Logroscino G; Messina S; Fini N; Mandrioli J
    J Neurol; 2017 Jan; 264(1):54-63. PubMed ID: 27778156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.
    Rosenbohm A; Liu M; Nagel G; Peter RS; Cui B; Li X; Kassubek J; Rothenbacher D; Lulé D; Cui L; Ludolph AC;
    J Neurol; 2018 Apr; 265(4):774-782. PubMed ID: 29392461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.
    Chen L; Zhang B; Chen R; Tang L; Liu R; Yang Y; Yang Y; Liu X; Ye S; Zhan S; Fan D
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1075-81. PubMed ID: 26124198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in young-adult ALS - results from a Portuguese cohort study.
    Oliveira Santos M; Gromicho M; Pinto S; De Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):620-623. PubMed ID: 32654518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic factors affecting diagnostic timeline of amyotrophic lateral sclerosis: a 15-year retrospective study.
    Fang T; Pacut P; Bose A; Sun Y; Gao J; Sivakumar S; Bloom B; Nascimento Andrade EI; Trombetta B; Ghasemi M
    Neurol Res; 2024 Sep; 46(9):859-867. PubMed ID: 38825034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community.
    Vázquez-Costa JF; Martínez-Molina M; Fernández-Polo M; Fornés-Ferrer V; Frasquet-Carrera M; Sevilla-Mantecón T
    Neurologia (Engl Ed); 2021 Sep; 36(7):504-513. PubMed ID: 34537164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
    Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
    Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS).
    Paganoni S; Macklin EA; Lee A; Murphy A; Chang J; Zipf A; Cudkowicz M; Atassi N
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):453-6. PubMed ID: 24981792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): Egyptian study.
    Rashed HR; Tork MA; Soliman R; Serag R; Fahmy N
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):220-222. PubMed ID: 32897109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic interval in amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Ichikawa Y; Igarashi O; Kinoshita M
    Clin Neurol Neurosurg; 2002 May; 104(2):87-9. PubMed ID: 11932036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
    Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.